Massimo Reichlin
Papers
1
Total Citations
18
H-Index
1
About
Massimo Reichlin is a leading voice in the ethics of emerging neurotechnology, best known for his critical analysis of Neuralink’s brain-computer interfaces (BCIs). His most-cited work, “Neuralink’s brain-computer interfaces: medical innovations and ethical challenges” (2025), dissects the landmark 2024 first human implant and subsequent innovations like the Blindsight vision-restoration device. Reichlin’s research bridges the gap between rapid technological advancement and responsible governance, exploring how BCIs can treat paralysis and blindness while raising profound questions about privacy, identity, and equity. With 18 citations on this pivotal paper alone, his contributions have shaped early discourse around regulatory frameworks for commercial neurotech. Reichlin’s work is essential reading for students and researchers navigating the intersection of clinical neuroscience and bioethics, offering a balanced perspective that neither dismisses innovation nor ignores its societal risks. His scholarship underscores the urgency of embedding ethical deliberation into the development of transformative brain-machine interfaces.
Research Focus
Key Achievements
Top Papers
- 1